Satellos Bioscience Stock Number Of Employees
| MSCLF Stock | USD 0.51 0.03 6.25% |
Fundamental analysis of Satellos Bioscience allows traders to better anticipate movements in Satellos Bioscience's stock price by examining its financial health and performance throughout various phases of its business cycle.
Satellos |
Satellos Bioscience OTC Stock Number Of Employees Analysis
Satellos Bioscience's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Satellos Bioscience Number Of Employees | 7 |
Most of Satellos Bioscience's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Satellos Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
| Competition |
Based on the recorded statements, Satellos Bioscience is currently employing 7.0 people. This is 99.94% lower than that of the Healthcare sector and 98.69% lower than that of the Biotechnology industry. The number of employees for all United States stocks is 99.96% higher than that of the company.
Satellos Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Satellos Bioscience's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Satellos Bioscience could also be used in its relative valuation, which is a method of valuing Satellos Bioscience by comparing valuation metrics of similar companies.Satellos Bioscience is currently under evaluation in number of employees category among its peers.
Satellos Fundamentals
| Return On Equity | -0.86 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 7.17 M | |||
| Shares Outstanding | 41.8 M | |||
| Shares Owned By Insiders | 9.30 % | |||
| Shares Owned By Institutions | 14.41 % | |||
| Price To Book | 1.10 X | |||
| Price To Sales | 295.34 X | |||
| Gross Profit | (793.97 K) | |||
| EBITDA | (4.49 M) | |||
| Net Income | (15.51 M) | |||
| Cash And Equivalents | 1.93 M | |||
| Cash Per Share | 0.06 X | |||
| Current Ratio | 1.04 X | |||
| Book Value Per Share | 0.20 X | |||
| Cash Flow From Operations | (5.03 M) | |||
| Earnings Per Share | (0.47) X | |||
| Market Capitalization | 15.29 M | |||
| Total Asset | 12.59 M | |||
| Net Asset | 12.59 M |
About Satellos Bioscience Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Satellos Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Satellos Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Satellos Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| PRNEX | T Rowe Price | |
| RPBAX | T Rowe Price | |
| PRDGX | T Rowe Price | |
| PRFDX | T Rowe Price | |
| RPBAX | T Rowe Price |
Other Information on Investing in Satellos OTC Stock
Satellos Bioscience financial ratios help investors to determine whether Satellos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Satellos with respect to the benefits of owning Satellos Bioscience security.